On 15 May 2026, Swissinfo reported that WHO member states sought a one-year extension to complete the Pathogen Access and Benefit-Sharing (PABS) annex of the Pandemic Agreement, targeting adoption at the World Health Assembly in May 2027.[7] The annex addresses rapid sharing of pathogen materials and genetic-sequence information in exchange for equitable access to vaccines, therapeutics, and diagnostics; negotiations had failed to reach consensus for the 2026 WHA.[7]
The delay exposes a persistent gap between pathogen discovery and guaranteed access to countermeasures. For a lunar settlement, where medical manufacturing capacity, biological diversity, and specialist personnel will be limited, the relevant risk is not only terrestrial pandemic importation but also delayed access to reference sequences, validated diagnostics, vaccine designs, and therapeutics. The PABS negotiations specifically cover laboratory networks, contractual arrangements, sequence information, and benefit definitions.[1]
The Ark team should track the PABS negotiations through the planned May 2027 decision and any earlier 2026 special WHA session.[9] Ark biological-containment standards should assume no automatic international supply guarantee: preserve independent genomic databases, diagnostic protocols, vaccine platforms, broad-spectrum therapeutics, and manufacturing capability, while designing diplomatic agreements for rapid exchange of pathogen data and countermeasures with Earth-based institutions.